Article

The Role of Ki-67 in HR+/HER2- Breast Cancer: a Real-world Study of 956 Patients

2022-03-01

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose: </bold>This retrospective study aimed to determine the most suitable cut-off value of Ki-67 expression and further explore the prognostic effect of Ki-67 in hormone receptor positive and human epidermal growth factor receptor 2 negative (HR+/HER2-) breast cancer;<bold>Methods: </bold>We assessed the Ki-67 expression of 956 patients with HR+/HER2 breast cancer diagnosed in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: af51c931-ce99-564b-bed5-77c4ae81df3c
DOI: 10.21203/rs.3.rs-1388786/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Role of Ki-67 in HR+/HER2- Breast Cancer: a Real-world Study of 956 PatientsDOI 10.21203/rs.3.rs-1388786/v1Read

Ki-67 as a prognostic marker according to breast cancer molecular subtypeSemantic proximity Read

The Ki67 index of preoperative breast cancer puncture is correlated with lymph node metastasis, ER, PR and AR expression: A retrospective study of real world dataSemantic proximity Read

Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast CancerSemantic proximity Read

Ki67 Assessment by qRT-PCR in OncotypeDx ® Breast Recurrent Score®: Low Correlation With IHC Assessment of ki67 and Prognostic Impact of ki67 RNA Level of Expression.Semantic proximity Read

Evaluating the Association of Ki 67 with Oncotype DX Recurrence Score in Early-Stage ER Positive/HER2 Negative Breast CancerSemantic proximity Read

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read

Histopathological and Clinical Features of HER2-Positive Breast Cancers across Hormone Receptor Subgroups: A Cross-Sectional AnalysisSemantic proximity Read

A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of ageSemantic proximity Read

Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer PatientsSemantic proximity Read

Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterationsSemantic proximity Read